Drug delivery for neuronopathic lysosomal storage diseases: evolving roles of the blood brain barrier and cerebrospinal fluid
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1573-7365
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Drug delivery for neuronopathic lysosomal storage diseases: evolving roles of the blood brain barrier and cerebrospinal fluid ; day:28 ; month:1 ; year:2022 ; pages:1-12
Metabolic brain disease ; (28.1.2022), 1-12
- Urheber
-
Sato, Yuji
Minami, Kohtaro
Hirato, Toru
Tanizawa, Kazunori
Sonoda, Hiroyuki
Schmidt, Mathias
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s11011-021-00893-3
- URN
-
urn:nbn:de:101:1-2022041718453472495491
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:27 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Sato, Yuji
- Minami, Kohtaro
- Hirato, Toru
- Tanizawa, Kazunori
- Sonoda, Hiroyuki
- Schmidt, Mathias
- SpringerLink (Online service)
Ähnliche Objekte (12)
The rapidly evolving view of lysosomal storage diseases
Lysosomal storage disease: aspartylglycosaminuria
Neonatal Expanded Screening toward lysosomal storage disorders
Improving enzyme replacement therapy for lysosomal storage diseases
Sphingolipid lysosomal storage diseases: from bench to bedside
Lipid‐induced lysosomal damage after demyelination corrupts microglia protective function in lysosomal storage disorders
The lysosomal storage disease fucosidosis: towards enzyme replacement therapy
SNX8 enables lysosome reformation and reverses lysosomal storage disorder
Mitochondria-associated ER membranes (MAMs) and lysosomal storage diseases
Lysosomal dysfunction disrupts presynaptic maintenance and restoration of presynaptic function prevents neurodegeneration in lysosomal storage diseases
Impairment of chaperone‐mediated autophagy leads to selective lysosomal degradation defects in the lysosomal storage disease cystinosis
Curated incidence of lysosomal storage diseases from the Taiwan Biobank
The rapidly evolving view of lysosomal storage diseases
Lysosomal storage disease: aspartylglycosaminuria
Neonatal Expanded Screening toward lysosomal storage disorders
Improving enzyme replacement therapy for lysosomal storage diseases
Sphingolipid lysosomal storage diseases: from bench to bedside
Lipid‐induced lysosomal damage after demyelination corrupts microglia protective function in lysosomal storage disorders
The lysosomal storage disease fucosidosis: towards enzyme replacement therapy
SNX8 enables lysosome reformation and reverses lysosomal storage disorder
Mitochondria-associated ER membranes (MAMs) and lysosomal storage diseases
Lysosomal dysfunction disrupts presynaptic maintenance and restoration of presynaptic function prevents neurodegeneration in lysosomal storage diseases
Impairment of chaperone‐mediated autophagy leads to selective lysosomal degradation defects in the lysosomal storage disease cystinosis
Curated incidence of lysosomal storage diseases from the Taiwan Biobank
The rapidly evolving view of lysosomal storage diseases
Lysosomal storage disease: aspartylglycosaminuria
Neonatal Expanded Screening toward lysosomal storage disorders
Improving enzyme replacement therapy for lysosomal storage diseases
Sphingolipid lysosomal storage diseases: from bench to bedside
Lipid‐induced lysosomal damage after demyelination corrupts microglia protective function in lysosomal storage disorders
The lysosomal storage disease fucosidosis: towards enzyme replacement therapy
SNX8 enables lysosome reformation and reverses lysosomal storage disorder
Mitochondria-associated ER membranes (MAMs) and lysosomal storage diseases
Lysosomal dysfunction disrupts presynaptic maintenance and restoration of presynaptic function prevents neurodegeneration in lysosomal storage diseases
Impairment of chaperone‐mediated autophagy leads to selective lysosomal degradation defects in the lysosomal storage disease cystinosis